CekFakta - Kalimasada

Request for fact check about

Setelah Vaksin Pfizer 2 kali

90% efektif lawan varian UK (B.1.1.7)
88% efektif lawan varian India (B.1617)
±80% efektif lawan varian Brazil (P.1)
75% efektif lawan varian AfrIka selatan (B.1.351)

Setelah vaksin Astrazeneca 2 kali

74% efektif lawan varian UK (B.1.1.7)
±65% efektif lawan varian Brazil (P.1)
60% efektif lawan varian India (B.1617)
50-60% efektif lawan varian Afrika selatan (B.1.351)

Setelah vaksin Sinovac 2 kali

70% efektif lawan varian Afrika selatan (B.1.351)
65% efektif lawan varian UK (B.1.1.7)
65% efektif lawan varian India (B.1617)
50% efektif lawan varian Brazil (P.1)

SUMBER:

1. https://www.kompas.com/sains/read/2021/05/06/140100623/studi-baru--3-vaksin-covid-19-efektif-melawan-varian-baru-virus-corona?page=all

2. https://theconversation.com/whats-the-indian-variant-responsible-for-victorias-outbreak-and-how-effective-are-vaccines-against-it-161574

3. https://www.newscientist.com/article/2267066-south-africa-rethinks-plans-after-variant-evades-astrazeneca-vaccine/

4. https://www.sciencemag.org/news/2021/04/chinese-covid-19-vaccine-maintains-protection-variant-plagued-brazil

5. https://www.google.com/amp/s/voi.id/en/amp/51693/experts-say-sinovac-vaccine-is-still-reliable-against-b1617

Click or copy-paste the url below in your browser to notify or invalidate the request.

Invalidate Request: https://kalimasada-1.turnbackhoax.id/menu-kalimasada/process.php?invalidate=19884

Notify Requesters: https://kalimasada-1.turnbackhoax.id/menu-kalimasada/process.php?notify=19884

From Cekfakta Kalimasada Whatsapp.